Challenges in delivering urban healthcare services during COVID-19 pandemic: a mixed-methods study in Ahmedabad, India.

Publication date: Jul 26, 2025

Type	Source	Name
disease	MESH	COVID-19 pandemic
pathway	REACTOME	Reproduction
disease	MESH	Non Communicable Diseases
disease	MESH	emergency
disease	MESH	infection
disease	MESH	morbidity
drug	DRUGBANK	Coenzyme M
drug	DRUGBANK	Esomeprazole
drug	DRUGBANK	Dimercaprol
drug	DRUGBANK	Serine
drug	DRUGBANK	Water
drug	DRUGBANK	Trestolone
disease	MESH	measles
pathway	KEGG	Measles
disease	MESH	infectious diseases
disease	MESH	virus disease
disease	MESH	AIDS
drug	DRUGBANK	Spinosad
disease	IDO	country
drug	DRUGBANK	Tretamine
pathway	REACTOME	Translation
drug	DRUGBANK	Hexadecanal
disease	IDO	facility
drug	DRUGBANK	Iron
drug	DRUGBANK	Naproxen
drug	DRUGBANK	Folic Acid
disease	MESH	tics
disease	MESH	malaria
pathway	KEGG	Malaria
drug	DRUGBANK	L-Threonine
disease	MESH	malnutrition
disease	MESH	hypertension
disease	MESH	asthma
pathway	KEGG	Asthma
disease	MESH	chronic obstructive pulmonary disease
disease	MESH	coronary artery disease
drug	DRUGBANK	Etoperidone
drug	DRUGBANK	Methacholine
disease	IDO	contact tracing
disease	IDO	history
disease	MESH	depression
drug	DRUGBANK	Ilex paraguariensis leaf
disease	MESH	psychological Well being
disease	MESH	anxiety
disease	IDO	role
disease	MESH	chronic diseases
disease	IDO	immunodeficiency
disease	MESH	Tuberculosis
pathway	KEGG	Tuberculosis
drug	DRUGBANK	Medical air
disease	MESH	vaccine preventable diseases
disease	IDO	quality

(Visited 1 times, 1 visits today)